ROBO.AI INC. financial statements

Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data ROBO.AI INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2020	FY2022	FY2022	FY2023	FY2024	FY2025
Revenue				37.3	12	0.95
Cost of revenue				49	9.33	0.36
Gross profit				-11.7	2.67	0.59
Research and development	1.86	0.73	15.9	24.4	4.48	0.06
General and administrative	9.04	10	23.6	169	91	157
Operating expenses	10.9	10.8	41	200	98	158
Operating income	-1.75	-10.8	-41	-212	-95.4	-157
Interest expense				3.25	2.69	9.8
Other non-operating income	-1.75	-2.3	-7.2	-54.7	-77.4	-10.5
Pre-tax income	-12.6	-13.1	-48.2	-267	-173	-168
Income tax			0
Income from continuing operations	-10.9	-10.8	-41
Net income to minority interests		-0.68	-0.54	-1.4	-0.19	-0.23
Net income	-11.9	-12.4	-47.7	-265	-173	-167
EBITDA	-1.69	-10.8	-41	-211	-94.6	-156
EPS, basic	-1.01	-1.01	-3.82	-18.50	-11.81	-10.59
EPS, diluted	-1.01	-1.01	-3.82	-18.50	-11.81	-10.59
Shares, basic (weighted)	11.9	11.9	12.2	14.3	14.6	15.8
Shares, diluted (weighted)	11.9	11.9	12.2	14.3	14.6	15.8

Balance sheet

	FY2020	FY2022	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	0.01	0.02	212	23.2	0.15	4.14
Receivables				2.34	75.3	74.7
Inventory			2.11	7.77	2.42	0.27
Other current assets		7.32	24.7	33.7	28.7	2.41
Total current assets		13.9	240	82.9	32.6	8
Property, plant and equipment		0.03	1.66	3.2	2.5	0.36
Lease right-of-use assets			5.33	9.23	6.38	0.07
Intangible assets			0.01	0.04	0.03	0.01
Long-term investments			2.89	15.9
Total assets		13.9	347	166	41.5	8.44
Accounts payable		8.11	4.91	25.1	25.3	29.3
Accrued liabilities			18.2	3.66	4.34	5.47
Deferred revenue				0.38	0.09
Short-term debt			0.49	0.27	0.17	0.12
Total current liabilities		69.4	66.5	98.2	103	125
Long-term debt			4.92
Lease liabilities			3.92	7.08	4.8
Total liabilities		69.4	75.4	105	108	125
Paid-in capital		209	577	634	679	798
Retained earnings		-252	-299	-565	-737	-904
Other comprehensive income		-10	-2.59	-4.29	-4.11	-5.68
Shareholders' equity		-52.5	274	64.8	-62.6	-112
Minority interests		-2.95	-2.58	-3.82	-3.97	-4.33
Total equity	-208	-55.5	272	60.9	-66.6	-116
Total liabilities and equity		13.9	347	166	41.5	8.44

Cash flow statement

	FY2020	FY2022	FY2022	FY2023	FY2024	FY2025
Net income	-12.6	-13.1	-48.2	-267	-173	-168
Depreciation and amortization	0.06	0.02	0.05	0.8	0.78	0.7
Stock-based compensation			3.2	23.3		117
Change in receivables				-6.27	0.85
Change in inventory			-1.67	2.64	28.9	1.82
Change in payables	0.12	0.25	-2.46	-4.13	-24.3	3.76
Cash from operations	-0.66	-6.11	-178	-138	33.6	-5.07
Capital expenditures			-1.21	-5.51	-0.16
Cash from investing	0.27	-0.02	-6.84	-21.2	-0.66	0.08
Debt repaid				-7.9	-0.5	-0.2
Stock issued		0.03	0
Cash from financing	0.22	6.18	393	-27	-55	8.83
Net change in cash	-0.18	0.05	212	-189	-22.1	4.04
Free cash flow			-179	-144	33.4
Interest paid			0.08	0.75	10

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $1.39 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	62.5%	Gross profit / revenue.
Operating margin	-16,538.0%	Operating income / revenue.
EBITDA margin	-16,464.0%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-17,639.0%	Pre-tax income / revenue.
Net margin	-17,615.0%	Net income / revenue.
Operating cash flow margin	-533.3%	Cash from operations / revenue.
Return on assets (ROA)	-670.6%	Net income / average total assets.
R&D / revenue	6.7%	Research and development expense / revenue.
Stock-based pay / revenue	12,320.0%	Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue	73.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-92.1%	Revenue vs the same period a year earlier. Only from a positive base.
Gross profit growth, 1y	-77.7%	Gross profit vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	-115.1%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y	-79.6%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-71.0%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y	8.1%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	8.9%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	5.8%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.06x	Current assets / current liabilities.
Quick ratio	0.63x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.03x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	1,475.0%	Total liabilities / total assets.
Interest coverage	-16.0x	Operating income / interest expense.
Working capital	-$116.6M	Current assets - current liabilities.
Goodwill and intangibles / assets	0.2%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$111.8M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.04x	Revenue / average total assets.
Fixed asset turnover	0.66x	Revenue / average property, plant and equipment.
Inventory turnover	0.26x	Cost of revenue / average inventory.
Days inventory	1,379 days	365 x average inventory / cost of revenue.
Receivables turnover	0.01x	Revenue / average receivables.
Days sales outstanding	28,813 days	365 x average receivables / revenue.
Days payables	27,997 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	2,195 days	Days inventory + days sales outstanding - days payables.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$10.59	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	-$10.59	Net income per basic share, as reported (split-adjusted).
Revenue per share	$0.06	Revenue / diluted weighted shares.
Operating cash flow per share	-$0.32	Cash from operations / diluted weighted shares.
Book value per share	-$7.08	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$7.08	Tangible book value / shares outstanding.
Cash per share	$0.26	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$235.0M	Share price x shares outstanding.
Enterprise value	$230.9M	Market cap + total debt - cash - short-term investments.
P/S	247x	Market cap / revenue.
EV/Sales	243x	Enterprise value / revenue.
Earnings yield	-71.2%	Net income / market cap (the inverse of P/E).

What was ROBO.AI INC.'s revenue in fiscal 2025?

ROBO.AI INC. reported revenue of $950.0K for fiscal 2025, 92.1% lower than the year before.

Was ROBO.AI INC. profitable in fiscal 2025?

No. It reported a net loss of $167.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to ROBO.AI INC.